ZNF30 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.787450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.308200E-01
Normal-vs-Stage2
9.459700E-02
Normal-vs-Stage3
5.831800E-02
Normal-vs-Stage4
1.996600E-01
Stage1-vs-Stage2
5.896100E-03
Stage1-vs-Stage3
4.265900E-02
Stage1-vs-Stage4
1.566200E-01
Stage2-vs-Stage3
2.672800E-01
Stage2-vs-Stage4
9.231400E-01
Stage3-vs-Stage4
2.270200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.078200E-01
Normal-vs-AfricanAmerican
1.051030E-01
Normal-vs-Asian
1.110440E-01
Caucasian-vs-AfricanAmerican
6.706200E-01
Caucasian-vs-Asian
7.229200E-01
AfricanAmerican-vs-Asian
8.503800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.693160E-01
Normal-vs-Female
2.069000E-01
Male-vs-Female
8.313200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.542200E-01
Normal-vs-Age(41-60Yrs)
3.148200E-01
Normal-vs-Age(61-80Yrs)
1.169970E-01
Normal-vs-Age(81-100Yrs)
8.620000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.269780E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.878000E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.374100E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.997380E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.199400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.359200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.974500E-02
Normal-vs-Daily Drinker
2.279400E-01
Normal-vs-Weekly Drinker
7.341900E-02
Normal-vs-Occasional Drinker
5.935400E-01
Normal-vs-Social Drinker
5.483600E-01
Non Drinker-vs-Daily Drinker
5.188400E-01
Non Drinker-vs-Weekly Drinker
4.343600E-01
Non Drinker-vs-Occasional Drinker
1.038970E-01
Non Drinker-vs-Social Drinker
4.923700E-02
Daily Drinker-vs-Weekly Drinker
9.595200E-01
Daily Drinker-vs-Occasional Drinker
2.983600E-01
Daily Drinker-vs-Social Drinker
2.822800E-01
Weekly Drinker-vs-Occasional Drinker
2.789600E-01
Weekly Drinker-vs-Social Drinker
2.529800E-01
Occasional Drinker-vs-Social Drinker
9.912400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.643400E-01
Normal-vs-Grade 2
1.996220E-01
Normal-vs-Grade 3
1.891820E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.877800E-02
Grade 1-vs-Grade 3
7.259800E-02
Grade 1-vs-Grade 4
2.643400E-01
Grade 2-vs-Grade 3
7.729800E-01
Grade 2-vs-Grade 4
1.996220E-01
Grade 3-vs-Grade 4
1.891820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.629600E-02
Normal-vs-NonDiabetic
2.425000E-01
Diabetic-vs-NonDiabetic
2.831400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.033500E-02
Normal-vs-NoPancreatitis
1.928790E-01
Pancreatitis-vs-NoPancreatitis
1.533640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.205800E-01
Normal-vs-N1
1.053440E-01
N0-vs-N1
1.797380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.729800E-01
Normal-vs-TP53-NonMutant
7.110600E-01
TP53-Mutant-vs-TP53-NonMutant
1.899610E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
